190 related articles for article (PubMed ID: 34674320)
1. Haploinsufficient tumor suppressor PRP4K is negatively regulated during epithelial-to-mesenchymal transition.
Clarke LE; Cook A; Mathavarajah S; Bera A; Salsman J; Habib E; Van Iderstine C; Bydoun M; Lewis SM; Dellaire G
FASEB J; 2021 Nov; 35(11):e22001. PubMed ID: 34674320
[TBL] [Abstract][Full Text] [Related]
2. PRP4K is a HER2-regulated modifier of taxane sensitivity.
Corkery DP; Le Page C; Meunier L; Provencher D; Mes-Masson AM; Dellaire G
Cell Cycle; 2015; 14(7):1059-69. PubMed ID: 25602630
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor alpha (ESR1)-signaling regulates the expression of the taxane-response biomarker PRP4K.
Lahsaee S; Corkery DP; Anthes LE; Holly A; Dellaire G
Exp Cell Res; 2016 Jan; 340(1):125-31. PubMed ID: 26712520
[TBL] [Abstract][Full Text] [Related]
4. Tinker, Tailor, Tumour Suppressor: The Many Functions of PRP4K.
Habib EB; Mathavarajah S; Dellaire G
Front Genet; 2022; 13():839963. PubMed ID: 35281802
[TBL] [Abstract][Full Text] [Related]
5. Loss of PRP4K drives anoikis resistance in part by dysregulation of epidermal growth factor receptor endosomal trafficking.
Corkery DP; Clarke LE; Gebremeskel S; Salsman J; Pinder J; Le Page C; Meunier L; Xu Z; Mes-Masson AM; Berman JN; Johnston B; Dellaire G
Oncogene; 2018 Jan; 37(2):174-184. PubMed ID: 28892043
[TBL] [Abstract][Full Text] [Related]
6. Elevated TGF-β1 and -β2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells.
Kim S; Lee J; Jeon M; Nam SJ; Lee JE
Cytokine; 2015 Sep; 75(1):151-8. PubMed ID: 26088755
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Yki/Yap subcellular localization and Hpo signaling by a nuclear kinase PRP4K.
Cho YS; Zhu J; Li S; Wang B; Han Y; Jiang J
Nat Commun; 2018 Apr; 9(1):1657. PubMed ID: 29695716
[TBL] [Abstract][Full Text] [Related]
8. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition.
Prasad CP; Chaurasiya SK; Guilmain W; Andersson T
J Exp Clin Cancer Res; 2016 Sep; 35(1):144. PubMed ID: 27623766
[TBL] [Abstract][Full Text] [Related]
9. Hard antler extract inhibits invasion and epithelial-mesenchymal transition of triple-negative and Her-2
Xu G; Zhao H; Xu J; Zhang Y; Qi X; Shi A
J Ethnopharmacol; 2021 Apr; 269():113705. PubMed ID: 33346025
[TBL] [Abstract][Full Text] [Related]
10. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
Yoshida T; Ozawa Y; Kimura T; Sato Y; Kuznetsov G; Xu S; Uesugi M; Agoulnik S; Taylor N; Funahashi Y; Matsui J
Br J Cancer; 2014 Mar; 110(6):1497-505. PubMed ID: 24569463
[TBL] [Abstract][Full Text] [Related]
11. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
12. Cell Type-Specific TGF-β Mediated EMT in 3D and 2D Models and Its Reversal by TGF-β Receptor Kinase Inhibitor in Ovarian Cancer Cell Lines.
Al Ameri W; Ahmed I; Al-Dasim FM; Ali Mohamoud Y; Al-Azwani IK; Malek JA; Karedath T
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336560
[TBL] [Abstract][Full Text] [Related]
13. [Inhibition of Histone Deacetylases Reverses Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through a Slug Mediated Mechanism].
Rahimian A; Barati G; Mehrandish R; Mellati AA
Mol Biol (Mosk); 2018; 52(3):474-481. PubMed ID: 29989579
[TBL] [Abstract][Full Text] [Related]
14. Sef Regulates Epithelial-Mesenchymal Transition in Breast Cancer Cells.
He Q; Gong Y; Gower L; Yang X; Friesel RE
J Cell Biochem; 2016 Oct; 117(10):2346-56. PubMed ID: 26950413
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-543 inhibits the proliferation, migration, invasion, and epithelial-mesenchymal transition of triple-negative breast cancer cells via down-regulation of ACTL6A gene.
Wang YL; Liang RH; Wang CY; Zhang RP; Wu SY; Han X; Zhang GL
Clin Transl Oncol; 2022 Jan; 24(1):84-92. PubMed ID: 34181232
[TBL] [Abstract][Full Text] [Related]
16. TRPM7 promotes the epithelial-mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling.
Liu L; Wu N; Wang Y; Zhang X; Xia B; Tang J; Cai J; Zhao Z; Liao Q; Wang J
J Exp Clin Cancer Res; 2019 Feb; 38(1):106. PubMed ID: 30819230
[TBL] [Abstract][Full Text] [Related]
17. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
19. nm23-H1 is a negative regulator of TGF-β1-dependent induction of epithelial-mesenchymal transition.
Zhao R; Gong L; Li L; Guo L; Zhu D; Wu Z; Zhou Q
Exp Cell Res; 2013 Mar; 319(5):740-9. PubMed ID: 23137649
[TBL] [Abstract][Full Text] [Related]
20. Loss of the Metastasis Suppressor NME1, But Not of Its Highly Related Isoform NME2, Induces a Hybrid Epithelial-Mesenchymal State in Cancer Cells.
Huna A; Nawrocki-Raby B; Padilla-Benavides T; Gavard J; Coscoy S; Bernard D; Boissan M
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
